SITANAC M used primarily in combination to treat type 2 diabetes mellitus by improving blood sugar control.Metformin is a biguanide antihyperglycemic agent that works by decreasing glucose production in the liver, delaying glucose absorption in the intestines, and increasing the body's sensitivity to insulin. Sitagliptin is a DPP-4 inhibitor that helps increase the pancreas's production of insulin and decrease the liver's glucose production by increasing natural substances called incretins. When combined with metformin, these two drugs complement each other by targeting different pathways to better control blood glucose levels. This combination is taken along with proper diet and exercise, and it helps prevent complications of diabetes such as kidney damage and nerve problems.
